A Dallas-based biotech company has nearly completed its reconstruction of the Tasmanian tiger just two years into its de-extinction project. The last known thylacine, commonly referred to as the

Colossal Biosciences, which intends to create proxy species of the woolly mammoth, dodo, and Tasmanian tiger, claims it has made genome editing breakthroughs that bring it closer to the lost marsupial wolf.

Colossal Biosciences says it's made a breakthrough toward the de-extinction of the thylacine, or Tasmanian tiger.

A well-preserved thylacine head was a gruesome sight — but it also contained RNA molecules crucial to reconstructing the extinct animal’s genome

Scientists at Colossal Biosciences may be a few steps closer to resurrecting a long-extinct carnivorous marsupial known as the Tasmanian tiger.

It's been close to a century since the last Tasmanian tiger on the planet died in captivity, but a group of scientists believe they have what it takes to

Also known as the Tasmanian wolf or thylacine, the Tasmanian tiger lived in Australia and became extinct when the last known tiger died in 1936 at Hobart Zoo.